Imugene

Sydney, Australia

Imugene is a publicly-listed biotechnology company with operations in America and Europe,

$8.6M raised

Apr 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Imugene raised?

Imugene has raised $8.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.

Who are Imugene's investors?

Imugene's investors include Precision BioSciences.

Where is Imugene headquartered?

Imugene is headquartered in Sydney, Australia.

What does Imugene do?

Imugene is a publicly-listed biotechnology company with operations in America and Europe,

What stage is Imugene at?

Imugene is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 23, 2026.

MLA

"Imugene — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/imugene. Accessed July 2, 2026.

APA

VCBacked. (2026). Imugene — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/imugene

Wikipedia (cite web)

{{cite web |title=Imugene — Funding & Investors |url=https://www.vcbacked.co/company/imugene |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 23, 2026.